{"id":8051,"date":"2025-09-21T19:39:00","date_gmt":"2025-09-21T12:39:00","guid":{"rendered":"https:\/\/www.globenewswire.com\/news-release\/2025\/09\/21\/3153552\/683\/en\/SHAREHOLDER-NOTICE-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Altimmune.html3153552"},"modified":"2025-09-21T19:40:21","modified_gmt":"2025-09-21T12:40:21","slug":"shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune","status":"publish","type":"post","link":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/","title":{"rendered":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune"},"content":{"rendered":"\n<p><strong>Faruqi &amp; Faruqi, LLP Securities Litigation Partner <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qif3zdtGVLUvM4GbXLDg7yR0Vwsqj3AM_lH9PmJjfXUKUYsRAlK86CI7k9ItJEdrZlH_ch5KwyEAPuYA5SQFrfnx1mlCqgs5tyEHc614ghcOcBKdcCcuJP1uy1HW0DpEkXQSPaUHVmQZQndKWTEb-w==\" rel=\"nofollow\" target=\"_blank\" title><strong>James (Josh) Wilson<\/strong><\/a><strong> Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options<\/strong><\/p>\n<p><strong>If you suffered losses exceeding $75,000 in <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9o7IZhv72QkElL7uLkYdJCxfy3ZR88RJE_uDVEYSZ2VgL3RQc2zH16aRLLh09WpK3lRSzcHl1QUAmsYfxqLSwGAel1g6pZHEdYlANlP5pto=\" rel=\"nofollow\" target=\"_blank\" title><strong>Altimmune<\/strong><\/a><strong> between August 10, 2023 and June 25, 2025 <\/strong>and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p align=\"center\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KJr5EMP2Om4sg3fXbms4zk7E230h8Om4nZjbQz85w0mCS930QEgmO9QV4c2qAfd2fIOYz5OzNiUMgRF-LvzUCKhTN65LV1oW3W49Zv7TP9xeI_y3Bre4TzyQw4Zwr-2i7HGCjfNCphlOkBox9RepiA==\" rel=\"nofollow\" target=\"_blank\" title><strong>[You may also click here for additional information]<\/strong><\/a><\/p>\n<p align=\"center\"><img decoding=\"async\" alt height=\"232.94px\" name=\"GNW_RichHtml_IMG\" src=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/c9cc79c9-7d02-437e-ae19-f9935c803726\/image1.png\" width=\"624.0px\"><\/p>\n<p>NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lMJVj8-wDTMOWOofVcoJopuLD3v5OPW3ixVBY8BwBcy6n30uRrf2tlxB5fJEhBGNH43l-7zz7gADIZ_HjWMsVWnVcX2bcGTqVhI7ltcx37c=\" rel=\"nofollow\" target=\"_blank\" title=\"Faruqi &amp; Faruqi, LLP\">Faruqi &amp; Faruqi, LLP<\/a>, a leading national securities law firm, is investigating potential claims against Altimmune, Inc. (\u201cAltimmune\u201d or the \u201cCompany\u201d) (NASDAQ: ALT) and reminds investors of the <strong>October 6, 2025 deadline<\/strong> to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.<\/p>\n<p>Faruqi &amp; Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N9AB3aH-UpjrtySq3HP2r7SqljSCW-ER6XYqC0oWWL8llDU_wRqG-0pDuj69V_IabrDMqaYvzlIQKs90vszjNItrZZjqCKzufEZJPAK9thw=\" rel=\"nofollow\" target=\"_blank\" title=\"www.faruqilaw.com\">www.faruqilaw.com<\/a>.<\/p>\n<p>According to the complaint, on June 26, 2025, Altimmune published a press release announcing topline results from the IMPACT Phase 2b MASH trial of&nbsp;Pemvidutide in the Treatment of MASH. While defendants had continuously provided inflated expectations ahead of these results, the analysis showed a pointed failure by the Company to achieve statistical significance in its analysis of the fibrosis reduction primary endpoint in its IMPACT Phase 2b MASH trial. In particular, while a positive trend in fibrosis improvement was observed, statistical significance was not met due to a higher-than-expected placebo response. When questioned about this concerning miss, defendants answered indifferently, attributing this result to the Phase 2 nature of the trial and stated that Altimmune was hoping for better results following the Phase 3 trial.<\/p>\n<p>Following this news, the price of Altimmune\u2019s common stock declined dramatically. From a closing market price of $7.71 per share on June 25, 2025, Altimmune\u2019s stock price fell to $3.61 per share on June 26, 2025, a decline of 53.2% in the span of just a single day.<\/p>\n<p>The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.&nbsp;&nbsp;<\/p>\n<p>Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Altimmune\u2019s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.<\/p>\n<p>To learn more about the <strong>Altimmune, Inc.<\/strong> class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N9AB3aH-UpjrtySq3HP2r3wUFvjsk9Xq0KGapM_ZHZMLSzcen2a4N_5TKebDZxTC4KRXrQa9d_Lx9p7R5SuQXWJThqIm7ACvN7v2CvnOaw0=\" rel=\"nofollow\" target=\"_blank\" title><strong>www.faruqilaw.com\/ALT<\/strong><\/a> or <strong>call<\/strong> Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p>Follow us for updates on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zi8E6_wERGM5sVndEiY9h8hGWoIK0GudmeFLVAm0EvHGTQ5nsehMF6121Gbx-5GBm4-KA9TvEDwCsFLUob3IOxVbFp_QyIGmlOY_cF7uGhOQ04aiOxUNFwgzqd-0cKtY\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uW_FUOtWUwpKi_uK22eWoNT5LaLly4puC84XQMTZSs-HmGMA0WXHbu3CWbmwZ-FDg7-JhVUp8Rqb4IAE50ezHA==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a>, or on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kAQ3OP3hlHViG7zde0-5NHRVnzMfzTct9ueGSOyLs5u1wN-lOOnN_H1wG0YDWxMCvURo8vlbD9FSg9nKZrhjNSRino11ZJQxkV14qNCcG2k=\" rel=\"nofollow\" target=\"_blank\" title=\"Facebook\">Facebook<\/a>.<\/p>\n<p>Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N9AB3aH-UpjrtySq3HP2rxdbdWHWpT_zHn93LnodordmkKma0oWUkG-kcn-vpnle1sX_thn6yNT-aYi_ZJa1djN3qwF81cUNLiCKN0ogmU4=\" rel=\"nofollow\" target=\"_blank\" title=\"www.faruqilaw.com\">www.faruqilaw.com<\/a>). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.<\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pEpTE5ZWoFDGO2j1sAvX4mntiPBohgkRR6K_c1gRJkVUytoOOWRI7Cx0rh-gCYN2MZZNtVkegn2mBe-6wzY53nw8MDfmgy_NMbXcTNFYCiGKSbB4U8-mkl6ev_4HCrBW0gZWPoqCThbW4cbXo6XnsItP7GG4nu6XptoBLBxW1Q14jj8EW-faUzCzyRr7nVU1Ep7j5IbJscHy5sMSjnGAjwCjXCRCzEsoDjZahaQgaj1GNYfhEpIbilk2ai-e0pDLby_DWAAIhXaEx97rpYXqqA==\" rel=\"nofollow\" target=\"_blank\" title>https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/0a3ffa98-3a81-480d-8139-a996190dbdca<\/a><\/p>\n<p><img decoding=\"async\" alt src=\"https:\/\/ml.globenewswire.com\/media\/MzIxOGQ5YjEtNmE4MS00OGIwLWExMDMtMzQ3MTNhMzBjNmQ2LTEwMjkyMDktMjAyNS0wOS0yMS1lbg==\/tiny\/Faruqi-Faruqi-LLP.png\" referrerpolicy=\"no-referrer-when-downgrade\">  <\/p>\n","protected":false},"excerpt":{"rendered":"<p> Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]  NEW YORK, Sept. 21, 2025 (GLOBE&#8230;<\/p>\n","protected":false},"author":1,"featured_media":8052,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[75,1406],"tags":[],"class_list":["post-8051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-globenewswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune<\/title>\n<meta name=\"description\" content=\"Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/Faruqi%20&amp;%20Faruqi,%20LLP%20Securities%20Litigation%20Partner%20James%20(Josh)%20Wilson%20Encourages%20Investors%20Who%20Suffered%20Losses%20Exceeding%20$75,000%20In%20Altimmune%20To%20Contact%20Him%20Directly%20To%20Discuss%20Their%20Options%20If%20you%20suffered%20losses%20exceeding%20$75,000%20in%20Altimmune%20between%20August%2010,%202023%20and%20June%2025,%202025%20and%20would%20like%20to%20discuss%20your%20legal%20rights,%20call%20Faruqi%20&amp;%20Faruqi%20partner%20Josh%20Wilson%20directly%20at%20877-247-4292%20or%20212-983-9330%20(Ext.%201310).%20[You%20may%20also%20click%20here%20for%20additional%20information]%20NEW%20YORK,%20Sept.%2021,%202025%20(GLOBE...\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune\" \/>\n<meta property=\"og:description\" content=\"Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/\" \/>\n<meta property=\"og:site_name\" content=\"Crypto Insider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yourcryptoinsider\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-21T12:39:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-21T12:40:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/c9cc79c9-7d02-437e-ae19-f9935c803726\/image1.png\" \/>\n<meta name=\"author\" content=\"Crypto Insider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Crypto Insider\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/\"},\"author\":{\"name\":\"Crypto Insider\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\"},\"headline\":\"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune\",\"datePublished\":\"2025-09-21T12:39:00+00:00\",\"dateModified\":\"2025-09-21T12:40:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/\"},\"wordCount\":575,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png\",\"articleSection\":[\"Business\",\"GlobeNewswire\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/\",\"name\":\"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Crypto Insider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png\",\"datePublished\":\"2025-09-21T12:39:00+00:00\",\"dateModified\":\"2025-09-21T12:40:21+00:00\",\"description\":\"Crypto and Blockchain News\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png\",\"width\":2560,\"height\":956},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Business\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/business\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"name\":\"Crypto Insider\",\"description\":\"Crypto and Blockchain News\",\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\",\"name\":\"Crypto Insider\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"width\":2048,\"height\":2048,\"caption\":\"Crypto Insider\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yourcryptoinsider\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vietnaminsider\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\",\"name\":\"Crypto Insider\",\"description\":\"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain\",\"sameAs\":[\"https:\\\/\\\/cryptoinsider.asia\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune","description":"Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE...","og_locale":"vi_VN","og_type":"article","og_title":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune","og_description":"Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE...","og_url":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/","og_site_name":"Crypto Insider","article_publisher":"https:\/\/www.facebook.com\/yourcryptoinsider","article_published_time":"2025-09-21T12:39:00+00:00","article_modified_time":"2025-09-21T12:40:21+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/c9cc79c9-7d02-437e-ae19-f9935c803726\/image1.png","type":"","width":"","height":""}],"author":"Crypto Insider","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Crypto Insider","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"3 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#article","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/"},"author":{"name":"Crypto Insider","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6"},"headline":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune","datePublished":"2025-09-21T12:39:00+00:00","dateModified":"2025-09-21T12:40:21+00:00","mainEntityOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/"},"wordCount":575,"commentCount":0,"publisher":{"@id":"https:\/\/cryptoinsider.asia\/#organization"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/09\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png","articleSection":["Business","GlobeNewswire"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/","url":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/","name":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Crypto Insider","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#primaryimage"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/09\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png","datePublished":"2025-09-21T12:39:00+00:00","dateModified":"2025-09-21T12:40:21+00:00","description":"Crypto and Blockchain News","breadcrumb":{"@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#primaryimage","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/09\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/09\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png","width":2560,"height":956},{"@type":"BreadcrumbList","@id":"https:\/\/cryptoinsider.asia\/vi\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cryptoinsider.asia\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/cryptoinsider.asia\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Business","item":"https:\/\/cryptoinsider.asia\/category\/business\/"},{"@type":"ListItem","position":4,"name":"SHAREHOLDER NOTICE: Faruqi &amp; Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune"}]},{"@type":"WebSite","@id":"https:\/\/cryptoinsider.asia\/vi\/#website","url":"https:\/\/cryptoinsider.asia\/vi\/","name":"Crypto Insider","description":"Crypto and Blockchain News","publisher":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cryptoinsider.asia\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/cryptoinsider.asia\/vi\/#organization","name":"Crypto Insider","url":"https:\/\/cryptoinsider.asia\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","width":2048,"height":2048,"caption":"Crypto Insider"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yourcryptoinsider","https:\/\/www.linkedin.com\/company\/vietnaminsider"]},{"@type":"Person","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6","name":"Crypto Insider","description":"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain","sameAs":["https:\/\/cryptoinsider.asia"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/09\/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-altimmune-scaled.png","jetpack-related-posts":[],"jetpack_likes_enabled":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/8051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/comments?post=8051"}],"version-history":[{"count":0,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/8051\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media\/8052"}],"wp:attachment":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media?parent=8051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/categories?post=8051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/tags?post=8051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}